Participant funding for BWXT ITG’s application for a Class IB nuclear substance processing facility operating licence
This participant funding offering is open from November 18, 2020 to January 22, 2021.
Participant funding notice
The CNSC will hold a public hearing on June 9 and 10, 2021, to consider an application from BWXT ITG for a Class IB nuclear substance processing facility operating licence. BWXT ITG is requesting a licence to operate a medical isotope facility located within an existing nuclear substance processing facility in Ottawa, Ontario, and currently operated by Nordion (Canada) Inc.
The CNSC is offering participant funding to assist Indigenous peoples, members of the public, and stakeholders in reviewing BWXT ITG’s application and associated documents, and in participating in the Commission hearing process by providing topic-specific interventions to the Commission.
Up to $75,000 in participant funding will be disbursed among all eligible applicants for the provision of new, distinctive and valuable information through informed and topic-specific interventions to the Commission. Funding will be awarded for the review of documentation, including CNSC staff’s documents and BWXT ITG’s Commission member documents, and for participation in the public Commission hearing. Funding for travel to the Commission hearing is within the scope of this opportunity. However, due to potential travel restrictions or limitations related to the COVID-19 pandemic, the Commission will announce at a later date whether there will be in-person oral presentations at the Commission hearing.
- Email: firstname.lastname@example.org
- Mail: Canadian Nuclear Safety Commission
c/o Participant Funding Program administrator
P.O. Box 1046, Station B
280 Slater Street
Ottawa, ON, Canada K1P 5S9
- Fax: 613-995-5086
Deadline for submitting a participant funding application: January 22, 2021
A funding review committee that is independent of the CNSC will consider all applications for funding and make recommendations on the allocation of funds.
For questions about this specific funding opportunity, contact:
Participant Funding Program Administrator
- Date modified: